Summit Privacy Policy

World Hepatitis Alliance Privacy Policy

At the World Hepatitis Alliance, we are committed to securing your personal information and being open and transparent about what we do with it. We will only use your personal information in accordance with all applicable laws concerning the protection of personal information. We will never do anything with your information that you would not reasonably expect us to do, having freely provided us with it.

This policy is written in accordance with the Data Protection Act 1998. It has been reviewed and updated thoroughly to comply with the changes proposed by the COI that came into effect in May 2018. If you have any questions about this Privacy Policy, please contact our Data Protection Officer at Unit 6, 27 Corsham Street, London N1 6DR United Kingdom email admin@worldhepatitisalliance.org 

How do we obtain your personal information?

We collect this information directly from you either when you email us or submit your information to us through the website. You may give this information to us when registering your interest for the World Hepatitis Summit. The only personal information we will collect and retain, is your full name, prefix, email, region and country, job title and the name of your organisation. 

As part of the registration process your information will be shared with the Professional Conference Organiser (PCO), whom World Hepatitis Alliance work with, in order to process your participation. This PCO will be treated as a data processing company and will have their own approved Data Protection Policy.

How do we use your information?

How we use your information is compliant on why you provided it to us in the first place. Largely, we will contact individuals in order to effectively continue to engage with them about the World Hepatitis Summit. This can consist of providing information about key milestones in the lead-up to the event. We also use your information to keep a record of your relationship with us, for internal administrative purposes and to let you know about changes to our services.

– Direct Marketing

By providing us with your email address we will send you communications about our work, campaigns and organisational direction. Occasionally, we may include information from partner or member organisations who support our work. You can opt-out of these marketing emails at any time and we include information on how you can say no to such marketing in our emails.

You can also let us know if you would prefer not to receive these communications at any time by email admin@worldhepatitisalliance.org, or writing to our Data Protection Officer at the address above.

Who do we share your information with?

All personal information is stored and processed in our UK office. We will not sell your details to any third parties, but we may sometimes share your information with our trusted service providers who are authorised to act on our behalf or with associated member organisations whom we work in partnership with to deliver and improve services for people affected by hepatitis.

When we collect your personal information we use strict procedures and security features to prevent unauthorised access. However, no data transmission over the Internet is 100% secure. As a result, while we try to protect your personal information, World Hepatitis Alliance cannot guarantee the security of any information you transmit to us and you do so at your own risk.

Accessing and updating your personal information

You can request access to any information we hold about you or to let us know if you would no longer like to receive communications from us by contacting our Data Protection Officer at World Hepatitis Alliance, Unit 6, 27 Corsham Street, London N1 6DR United Kingdom email admin@worldhepatitisalliance.org.  Equally, please let us know of any changes to your personal information.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

The role of decentralised and community-led services in accelerating progress towards elimination.

Role of harm reduction.